CMN Weekly (24 March 2023) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Mar. 24, 2023
News

Top picks

Research

Industry

Detection

Reviews

Meetings

  • CRISPR as a cancer and regenerative medicine research tool is an international two-day symposium at the Karolinska Institutet on 25-28 May. It brings together leading international experts in CRISPR technology and CRISPR applications in basic research in cancer and regenerative medicine.

Editor note: This article was published on 24th March 2023. In the original text, it was incorrectly stated in the Research section that: 'Chinese researchers have developed a split-tracrRNA system for improved scalability of tracrRNA synthesis. The split-tracrRNA, tracrRNA(41 + 23).....' The researchers behind that study were in Korea, and the text was updated on 27th March 2023 to reflect this.

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (24 March 2023) - Your Weekly CRISPR Medicine News
News: CMN Weekly (24 March 2023) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
Transthyretin Amyloidosis, ATTR, (NCT05697861)
Sponsors:
Intellia Therapeutics
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transthyretin Amyloidosis, ATTR, (NCT06128629)
Sponsors:
Intellia Therapeutics
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine